Skip to main navigation Skip to search Skip to main content

Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells

  • Zhizhong Li
  • , Shideng Bao
  • , Qiulian Wu
  • , Hui Wang
  • , Christine Eyler
  • , Sith Sathornsumetee
  • , Qing Shi
  • , Yiting Cao
  • , Justin Lathia
  • , Roger E. McLendon
  • , Anita B. Hjelmeland
  • , Jeremy N. Rich
  • Duke University Medical Center
  • Cleveland Clinic Foundation

Research output: Contribution to journalArticlepeer-review

1203 Citations (Scopus)

Abstract

Glioblastomas are lethal cancers characterized by florid angiogenesis promoted in part by glioma stem cells (GSCs). Because hypoxia regulates angiogenesis, we examined hypoxic responses in GSCs. We now demonstrate that hypoxia-inducible factor HIF2α and multiple HIF-regulated genes are preferentially expressed in GSCs in comparison to non-stem tumor cells and normal neural progenitors. In tumor specimens, HIF2α colocalizes with cancer stem cell markers. Targeting HIFs in GSCs inhibits self-renewal, proliferation, and survival in vitro, and attenuates tumor initiation potential of GSCs in vivo. Analysis of a molecular database reveals that HIF2A expression correlates with poor glioma patient survival. Our results demonstrate that GSCs differentially respond to hypoxia with distinct HIF induction patterns, and HIF2α might represent a promising target for antiglioblastoma therapies.

Original languageEnglish
Pages (from-to)501-513
Number of pages13
JournalCancer Cell
Volume15
Issue number6
DOIs
Publication statusPublished - 2 Jun 2009
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CELLCYCLE
  • STEMCELL

Fingerprint

Dive into the research topics of 'Hypoxia-Inducible Factors Regulate Tumorigenic Capacity of Glioma Stem Cells'. Together they form a unique fingerprint.

Cite this